Balyasny Asset Lc has invested 0% in Seattle Genetics, Inc. The stock's 52-week range is $45.31 to $71.32, and its 3-month range is $51.06 to $65.15. About 926,614 shares traded.
California Public Employees Retirement System lowered its stake in Seattle Genetics, Inc. It has outperformed by 58.98% the S&P500. Bnp Paribas Arbitrage Sa sold 112 shares as the company's stock rose 2.08% with the market. The biotechnology company reported ($0.19) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.42) by $0.23. Lagoda Investment Management Lp who had been investing in Seattle Genetics Inc for a number of months, seems to be less bullish one the $7.44B market cap company. The stock increased 0.09% or $0.02 during the last trading session, reaching $22.35. Bloomin' Brands, Inc. (NASDAQ:BLMN) has risen 8.82% since January 13, 2017 and is uptrending. It also increased its holding in Alamos Gold Inc New Com by 6,938 shares in the quarter, for a total of 70,051 shares, and has risen its stake in Transmontaigne Partners LP Com (NYSE:TLP). Its up 0.83, from 1.5 in 2017Q2. It dropped, as 15 investors sold K12 Inc. shares while 35 reduced holdings. 12 funds opened positions while 23 raised stakes. There were 60 sold out positions, amounting to 2.75 million shares. (NASDAQ:RGLS) for 13,200 shares. Citigroup owns 41,931 shares. (NASDAQ:RGLS) for 580,000 shares. Bnp Paribas Arbitrage Sa accumulated 0% or 101 shares. Capital Interest Ca reported 61,330 shares. Ecor1 Capital Ltd Llc invested 0.87% in Regulus Therapeutics Inc. The firm has "Overweight" rating given on Wednesday, September 7 by Morgan Stanley. Tracking ROA value which gives an idea as to how efficient management is at using its assets to generate earnings. Services Automobile Association reported 43,100 shares stake. State Street reported 0% in United States Lime & Minerals, Inc. (NYSE:MD) to report earnings on February, 6. State Street has invested 0% in K12 Inc. Art Advsr Limited Company invested 0% in Regulus Therapeutics Inc. Cipher Capital Limited Partnership holds 26,500 shares or 0.12% of its portfolio.
Investors sentiment decreased to 0.78 in 2017 Q3. Its down 0.52, from 1.3 in 2017Q2. It is negative, as 25 investors sold Bloomin' Brands, Inc. shares while 68 reduced holdings. 30 funds opened positions while 30 raised stakes. 140.23 million shares or 2.00% more from 137.48 million shares in 2017Q2 were reported. Shine Invest Advisory Svcs reported 157 shares stake. The SI to Southwestern Energy Company's float is 9.17%. Foundry Prtn Ltd Liability has 13,550 shares for 0.02% of their portfolio. Pictet Asset Mngmt Ltd has invested 0.2% in Seattle Genetics, Inc. (NASDAQ:SGEN) shares. HIMES VAUGHN B had sold 6,377 shares worth $305,423. Toronto Dominion Bankshares invested in 4,219 shares or 0% of the stock. (NASDAQ:SGEN). Caisse De Depot Et Placement Du Quebec invested 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Raymond James Financial Services Advsrs Inc owns 4,654 shares or 0% of their USA portfolio. Fjarde Ap invested in 26,874 shares. Spark Inv Management Limited Co, New York-based fund reported 183,500 shares. (NASDAQ:SGEN) traded down 1.36% on Tuesday, hitting $60.70.
Seattle Genetics (NASDAQ:SGEN) last released its earnings results on Thursday, October 26th. (NASDAQ:SGEN) for 525,000 shares.
Kane to break all English goal records, says Pochettino
Tottenham boss Mauricio Pochettino singled out Kane for praise and backed the 24-year-old to keep building on his achievements. But that's what Kane did in 2017.
Turning to TAL Education Group (NYSE:TAL), its shares were trading at $32.4 a retreat of $-0.86, on the trading floor. Credit Suisse Ag reported 0% in K12 Inc.
Since December 15, 2017, it had 0 insider buys, and 2 sales for $7.99 million activity. Over the last quarter, insiders sold 138,378 shares of company stock worth $8,121,108. Shares for $260,967 were sold by Cline Darren S. SIMPSON TODD E also sold $236,455 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) was sold by DOBMEIER ERIC on Monday, August 28.
In related news, insider Clay B. Siegall sold 18,832 shares of the company's stock in a transaction dated Friday, November 10th. BlackRock Inc. lifted its stake in Seattle Genetics by 2.6% in the second quarter. DRACHMAN JONATHAN G sold $475,414 worth of stock. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. Therefore 20% are positive. The stock has "Hold" rating by BMO Capital Markets on Monday, June 12. HC Wainwright restated a buy rating and issued a $75.00 price target on shares of Seattle Genetics in a research note on Friday, October 27th. (NASDAQ:SGEN) on Thursday, July 27 with "Hold" rating. (NASDAQ:SGEN) earned "Outperform" rating by RBC Capital Markets on Monday, September 14. On Friday, October 27 the stock rating was maintained by SunTrust with "Hold". The firm earned "Hold" rating on Wednesday, November 8 by Oppenheimer. Raymond James maintained it with "Outperform" rating and $24 target in Thursday, July 27 report. The stock of Seattle Genetics, Inc. (NASDAQ:CUTR) has "Buy" rating given on Tuesday, September 12 by Roth Capital. 1 is equivalent to a buy rating, 3 a hold rating, and 5 a sell rating. (NYSE:LRN) rating on Wednesday, July 12. The stock of A. O. Smith Corporation (NYSE:AOS) earned "Buy" rating by Jefferies on Friday, September 23.